It was reported that on (b)(6)2021, a mitraclip procedure was performed to treat mitral regurgitation grade 4.A xtw (lot: 00718u307) was implanted successfully, reducing mr to grade 2.Four weeks after the procedure, mr was recurrent grade 4 due to a torn posterior leaflet.The clip remained securely attached to the anterior leaflet.No intervention was performed at the time.On (b)(6)2024, a mitraclip re-intervention was performed to treat severe degenerative mitral regurgitation causing severe dyspnea.The original original xtw clip (00718u307) was attached to the anterior leaflet but there was a small amount of posterior leaflet grasped.A ntw mitraclip (lot; 31108r1106) was attempted to be implanted.After multiple unsuccessful attempts at grasping and capturing the leaflets, the clip was removed.A replacement xtw (lot: 31113r1022) was implanted successfully lateral to the original xtw clip (00718u307).The procedure ended with mr reduced to grade 2.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history did not indicate a lot-specific product issue.All available information was investigated, and a cause for the reported migration (partial clip movement) cannot be determined.Additionally, a cause for the unspecified tissue injury resulting in recurrent mitral valve insufficiency/regurgitation (mr) cannot be determined.Dyspnea; however, is a cascading effect of the recurrent mr.Mitral regurgitation, tissue damage/injur and dyspnea are known possible complications associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|